Y Combinator Post

▤ Summary

Y Combinator highlights Enjamb, a startup building full-stack AI agents for biopharma research and development. The platform aims to handle work across preclinical research, clinical trials, regulatory drafting, and statistical programming in one auditable workspace. The post positions the product as a way to reduce handoff friction and compress months of work into days. It also includes a demo call-to-action and launch celebration, which makes the item clearly product-focused.

▦ Linked Companies